Novo Nordisk Stock Rises as UBS Upgrades Ozempic Maker, Calls Sell-Off 'Overdone'
Key Takeaways Novo Nordisk shares rose Wednesday on the company's home market in Denmark and in the U.S. after UBS analysts ...
PulteGroup upgraded to Buy at UBS; MTH named top homebuilder pick
UBS Securities on Wednesday upgraded PulteGroup (NYSE:PHM) stock to Buy from Neutral, highlighting promising margins, while ...
UBS upgrades Bank of America to Buy and boosts price target
UBS analysts upgrade Bank of America (BAC) to Buy from Neutral and lift their price target to $53 from $43. The analysts ...
UBS investigates undisclosed Nazi-linked accounts at Credit Suisse
Authorities entered impeached President Yoon Suk Yeol's compound, evading a crowd of protesters outside, but were confronted ...
Wendy’s price target lowered to $17 from $20 at UBS
UBS lowered the firm’s price target on Wendy’s (WEN) to $17 from $20 and keeps a Neutral rating on the shares. The firm has a more optimistic ...
UBS Shares Rise as Exane Upgrades on Likely Buyback Increase
UBS Group AG shares rose the most in two months as analysts at BNP Paribas Exane recommended buying on expectations the Swiss ...
UBS boss warns against excessive banking regulation ahead of overhaul
Switzerland should not set rules for its banking sector that put it at a disadvantage, UBS CEO Sergio Ermotti was quoted as ...
Series of factors will conspire to limit Hong Kong stock gains in 2025: UBS
The Swiss bank expects the city’s benchmark index to rise above 20,000 by year-end, implying a gain of 3.7 per cent from ...
AI stocks could continue their growth despite high valuations, says UBS
AI stocks and the "Magnificent Seven" were clear winners in 2024. But after a solid year of growth and high valuations, will that momentum continue in 2025? Perhaps, says UBS. In a note, UBS head of U ...
United Airlines price target raised to $140 from $139 at UBS
UBS raised the firm’s price target on United Airlines (UAL) to $140 from $139 and keeps a Buy rating on the shares. UBS says the bar is high ...
Novo Nordisk upgraded at UBS as analysts call CagriSema sell-off "overdone"
Investing.com - Novo Nordisk (CSE: NOVOb ) remains the "most exciting growth story" in the European pharmaceutical sector and ...
Investing4h
UBS' survey results point to Nvidia, Microsoft and OpenAI as key AI winners
Investing.com -- Nvidia (NASDAQ: NVDA ), Microsoft (NASDAQ: MSFT ), and OpenAI are the key AI beneficiaries, UBS analysts said, citing results of its latest enterprise AI survey. The survey, which ...